School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Charles Perkins Centre, The University of Sydney, Sydney, Australia.
Nat Commun. 2022 May 11;13(1):2603. doi: 10.1038/s41467-022-29943-9.
Human cytomegalovirus reactivation is a major opportunistic infection after allogeneic haematopoietic stem cell transplantation and has a complex relationship with post-transplant immune reconstitution. Here, we use mass cytometry to define patterns of innate and adaptive immune cell reconstitution at key phases of human cytomegalovirus reactivation in the first 100 days post haematopoietic stem cell transplantation. Human cytomegalovirus reactivation is associated with the development of activated, memory T-cell profiles, with faster effector-memory CD4 T-cell recovery in patients with low-level versus high-level human cytomegalovirus DNAemia. Mucosal-associated invariant T cell levels at the initial detection of human cytomegalovirus DNAemia are significantly lower in patients who subsequently develop high-level versus low-level human cytomegalovirus reactivation. Our data describe distinct immune signatures that emerged with human cytomegalovirus reactivation after haematopoietic stem cell transplantation, and highlight Mucosal-associated invariant T cell levels at the first detection of reactivation as a marker that may be useful to anticipate the magnitude of human cytomegalovirus DNAemia.
人巨细胞病毒再激活是人异体造血干细胞移植后主要的机会性感染,与移植后免疫重建有着复杂的关系。在这里,我们使用液质联用技术在造血干细胞移植后 100 天内人巨细胞病毒再激活的关键阶段定义先天和适应性免疫细胞重建的模式。人巨细胞病毒再激活与激活的、记忆 T 细胞特征的发展相关,在低水平与高水平人巨细胞病毒 DNA 血症的患者中,效应记忆 CD4 T 细胞的恢复更快。在人巨细胞病毒 DNA 血症最初检测时,黏膜相关不变 T 细胞水平在随后发生高水平与低水平人巨细胞病毒再激活的患者中显著更低。我们的数据描述了在造血干细胞移植后出现的与人巨细胞病毒再激活相关的独特免疫特征,并强调在再激活的最初检测时黏膜相关不变 T 细胞水平作为一个标志物,可能有助于预测人巨细胞病毒 DNA 血症的程度。